Intercept Pharmaceuticals buy BiotechBee
Start price
20.09.22
/
40%
€16.65
Target price
31.01.23
€32.00
Performance (%)
-17.72%
End price
30.09.22
€13.70
Summary
This prediction ended on 30.09.22 with a price of €13.70. The prediction for Intercept Pharmaceuticals disappointed with a performance of -17.72%. BiotechBee has 40% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Intercept Pharmaceuticals | - | - | - |
| iShares Core DAX® | 1.804% | -0.748% | 13.168% |
| iShares Nasdaq 100 | -0.182% | -3.412% | 39.976% |
| iShares Nikkei 225® | 0.413% | -7.381% | 18.776% |
| iShares S&P 500 | 0.664% | -1.941% | 28.141% |
According to BiotechBee what are the pros and cons of Intercept Pharmaceuticals for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Intercept Pharmaceuticals diskutieren
Buy mit Kursziel 32,0
In the thread Trading Intercept Pharmaceuticals
Stopped prediction by BiotechBee for Intercept Pharmaceuticals
Intercept Pharmaceuticals
Start price
Target price
Perf. (%)
€13.70
30.09.22
30.09.22
€9.00
31.01.23
31.01.23
-12.08%
03.01.23
03.01.23
Could be very worthwhile Investment >20% year
